bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.06.14.732157

Neuronal Activity-Dependent Electroosmosis and Its Potential Role in Interstitial Fluid Flow in the Glymphatic System

Abstract

The mechanisms driving interstitial fluid flow through brain parenchyma remain unresolved, limiting our understanding of how fluid transport contributes to glymphatic waste clearance and broader aspects of brain metabolism and neuronal activity. Existing theories based on diffusion or pressure gradients fail to explain sustained, directional flow through the tortuous extracellular space (ECS), particularly under normal physiologic conditions. Here we propose that electroosmosis, fluid motion driven by endogenous electric fields acting on charged brain tissue, provides a biophysically consistent mechanism for intraparenchymal interstitial fluid transport while generating pressure distributions favorable for periarterial influx and perivenous efflux. Using computational modeling informed by anatomical reconstructions of ECS microstructure and local field potential (LFP) recordings, we show that electroosmotic flow generates physiologically realistic velocities and reproduces brain state dependent differences in glymphatic transport, including the enhanced glymphatic flow observed during sleep compared to wakefulness. A physics-informed reduced-order model (ROM) further demonstrates that these microstructure-resolved results upscale consistently to tissue-level transport. Moreover, electroosmotic flow can induce directional pressure gradients across perivascular interfaces, facilitating both influx and efflux. This mechanism provides a unifying framework linking neuronal activity, parenchymal flow, and compartmental pressure regulation. In contrast, pressure gradients substantially larger than physiological estimates generated much smaller velocities and failed to account for the observed transport rates. These findings address a major gap in glymphatic physiology and suggest that modulation of electric field properties, via endogenous activity or external neuromodulation, could serve as a therapeutic strategy to enhance solute clearance in neurological disorders. Significance StatementA major challenge in brain physiology is the lack of a unifying physical model that explains how fluid moves through the narrow and tortuous extracellular space; a process essential for nutrient distribution and waste clearance. Existing frameworks cannot account for sustained, directional transport under normal physiological conditions. We show that electroosmosis (fluid motion generated when endogenous neuronal electric fields act on charged cellular surfaces) provides a biophysically consistent mechanism for this transport. Using realistic extracellular microstructures and a validated tissue scale reduced order model, our model reproduces experimentally observed brain state dependent transport. Establishing electroosmosis as a possible contributor to interstitial fluid movement offers a new conceptual basis for linking neuronal activity to fluid circulation and for guiding strategies to enhance brain clearance.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hemmati, P., Wang, A. C., Prins, M. L., Giza, C. C., Kavehpour, P.. 2026-06-18. Neuronal Activity-Dependent Electroosmosis and Its Potential Role in Interstitial Fluid Flow in the Glymphatic System. https://doi.org/10.64898/2026.06.14.732157

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Surfactant-Assisted Colorimetric Signal Enhancement in Paper-Based Glucose Sensing

Paper-based colorimetric sensors offer a low-cost and accessible platform for point-of-care (POC) analysis, but enzyme activity loss during coating and drying can weaken analytical signals and require high enzyme loadings or complex immobilization procedures. Although surfactants are widely used to improve wettability in paper-based assays, their potential contribution to colorimetric performance beyond these effects remains unclear. Here, we investigated surfactant-assisted colorimetric signal enhancement in a glucose assay implemented on a 96-puddle paper plate (96-PPP) and identified Tween 20 as the most effective surfactant. Its effect on detection performance became more pronounced as glucose oxidase (GOx) loading decreased; at 0.1 mg/mL GOx, Tween 20 lowered the limit of detection (LoD) from 0.113 to 0.034 mg/mL (approximately 3.3-fold) over a working range of 0-5 mg/mL, despite no statistically significant change in the measured contact angle at this loading. Tween 20 had no appreciable effect on the reaction in solution but preserved 95% of the apparent reaction rate constant after drying, compared with 11% without it, and atomic force microscopy (AFM) revealed a more dispersed dried enzyme morphology on mica. Tween 20-containing sensors also showed slower signal decay during repeated wetting-drying cycles and thermal stress, retained 77% (vs 26%) of the response at 400 mM NaCl, and exhibited within-PPP and between-batch coefficients of variation (CVs) below 10% (vs 12.3-19.5%), while maintaining glucose selectivity over potentially interfering molecules. These results indicate that Tween 20 enhances paper-based glucose sensing beyond wettability, in part by retaining enzyme cascade activity during drying, although the contributions of the individual enzymes and the underlying mechanism remain to be established.

bioengineering↗

Engineering CAR-T cells to remodel the mucin-rich cancer cell glycocalyx

The dense glycocalyx of cancer cells can restrict immune-cell access to surface antigens and limit CAR-T cell activity. Here, we show that mucin density and epitope position determine how glycocalyx remodeling affects CAR-T cell recognition and killing. We identify KLK5 as a human protease that cleaves tumor-associated mucins, increases access to membrane-proximal antigens, and enhances CAR-T cell function. We then engineer CAR-T cells to display or secrete KLK5, enabling remodeling of the tumor glycocalyx during antigen recognition. KLK5-engineered CAR-T cells improved tumor control across multiple xenograft models, and KLK5-secreting MUC17 CAR-T cells produced the strongest in vivo benefit, prolonging survival compared with conventional MUC17 CAR-T cells. These findings show that CAR-T cells can be engineered to breach the mucin-rich glycocalyx while preserving accessible target epitopes.

bioengineering↗

Wall stiffening is a primary contributor to motility loss in Crohn's disease: an electromechanical modeling study

Fibrotic strictures are among the most disabling complications of Crohn's disease, permanently narrowing the bowel and impairing motility, yet no approved therapy reverses them. Chronic inflammation alters pacemaker-network coupling, smooth-muscle excitability, and calcium-dependent contractility, while fibrosis thickens the bowel wall, narrows the lumen, and changes tissue mechanics. The relative contributions of these coupled electrical, contractile, and structural alterations to motility loss remain unclear. To address this gap, we develop an integrated electromechanical finite-element framework for fibrostenosing Crohn's disease that couples a fibrosis-driven growth model with a FitzHugh-Nagumo electromechanical model. A full-factorial 25 design of experiments is used to quantify the relative effects of electrical diffusivity, excitation threshold, peak active stress, wall stiffness, and hypertrophic remodeling on cyclic lumen-volume deformation. Motility is quantified by the standard deviation of lumen volume over one contraction cycle. Within the parameter ranges examined, increased wall stiffness emerged as the dominant contributor to motility loss, followed by impaired smooth-muscle contractility. Changes in excitation threshold, hypertrophic remodeling, and electrical diffusivity produced substantially smaller effects. Pairwise interactions were small relative to the dominant main effects, indicating that the mechanisms contributed largely through their individual effects. Our findings suggest that limiting wall stiffening while preserving smooth-muscle contractile function may provide a therapeutic strategy for maintaining intestinal motility in fibrostenosing Crohn's disease.

bioengineering↗